Journal of the anus, rectum and colon · 2026
Verification of the Storage Stability of Fecal Hemoglobin in Stool Sampling Bottle Using Improved Buffer - A Pilot Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fukuzawa Masakatsu, Naito Sakiko, Kono Shin, Yamauchi Yoshiya, Morise Takashi, Uchida Kumiko, Kagawa Yasuyuki, Muramatsu Takahiro, Enomoto Shiori, Takehara Shizuka, Hosaka Norimitsu, Itoi Takao
Аннотация
OBJECTIVE: The temperature and duration of sample storage is known to affect the accuracy of the fecal immunochemical test (FIT). This study compared an improved stool collection buffer with the conventional buffer on the fecal hemoglobin (Hb) correlation and high-temperature stability and simultaneously evaluated the stability of fecal transferrin (Tf) and fecal calprotectin (FC).
METHODS: From June 2021 to December 2024, 130 stool samples collected from patients with informed consent were analyzed. Fecal Hb, Tf, and FC were measured in samples stored in both buffers, followed by correlation and stability assessments. High-temperature stability was evaluated at 37°C for 1 week.
RESULTS: The improved buffer showed strong correlations with the conventional buffer for three markers (r ≥ 0.95; slope 1.00 ± 0.10). In the high-temperature stability test, residual reactivities were assessed for Hb ≥10 μg/g, Tf ≥10 μg/g, and FC ≥50 μg/g. Hb residual reactivity was significantly higher with the improved buffer (p < 0.01), while Tf maintained high stability (> 90%) in both buffers. FC showed reduced stability in the conventional buffer under prolonged high-temperature exposure, whereas the improved buffer demonstrated better preservation. The improved buffer also maintained higher Hb stability at elevated concentrations (≥30 μg/g).
CONCLUSIONS: The improved stool collection buffer effectively addressed the limitations of the conventional buffer by providing better Hb stability under high-temperature and high-concentration conditions, while preserving excellent stability for Tf and FC. These findings support its potential utility for postal stool collection in FIT-based colorectal cancer screening.
METHODS: From June 2021 to December 2024, 130 stool samples collected from patients with informed consent were analyzed. Fecal Hb, Tf, and FC were measured in samples stored in both buffers, followed by correlation and stability assessments. High-temperature stability was evaluated at 37°C for 1 week.
RESULTS: The improved buffer showed strong correlations with the conventional buffer for three markers (r ≥ 0.95; slope 1.00 ± 0.10). In the high-temperature stability test, residual reactivities were assessed for Hb ≥10 μg/g, Tf ≥10 μg/g, and FC ≥50 μg/g. Hb residual reactivity was significantly higher with the improved buffer (p < 0.01), while Tf maintained high stability (> 90%) in both buffers. FC showed reduced stability in the conventional buffer under prolonged high-temperature exposure, whereas the improved buffer demonstrated better preservation. The improved buffer also maintained higher Hb stability at elevated concentrations (≥30 μg/g).
CONCLUSIONS: The improved stool collection buffer effectively addressed the limitations of the conventional buffer by providing better Hb stability under high-temperature and high-concentration conditions, while preserving excellent stability for Tf and FC. These findings support its potential utility for postal stool collection in FIT-based colorectal cancer screening.